Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTERF1 pseudogene 1 (MTERF1P1) is a pseudogene related by sequence homology to the functional mitochondrial transcription termination factor 1 (MTERF1) but does not code for a functional protein. Pseudogenes are genomic DNA sequences similar to known genes but are typically non-functional due to mutations or lack of regulatory sequences required for expression. There is currently no evidence suggesting that MTERF1P1 has a biological or therapeutic role, nor any known associations with disease, drug interaction, or utility as a biomarker. In contrast, the functional MTERF1 protein is a mitochondrial transcription termination factor involved in mitochondrial DNA replication and transcription regulation[2][3][4], but references to "MTERF1P1" indicate a non-coding, non-target pseudogene form. Key notes: - MTERF1P1 is not a receptor, drug target, enzyme, transporter, or functionally active molecule; it is a pseudogene. - No scientific or clinical literature supports a therapeutic, diagnostic, or mechanistic role for MTERF1P1. - If the intended target is functional Mitochondrial transcription termination factor 1 (MTERF1), refer to "MTERF1" not MTERF1P1[3][4]. Summary: This entry is likely incorrect as a therapeutic or biological target since pseudogenes like MTERF1P1 do not produce functional proteins and have no established roles as drug targets or disease factors. If you are interested in the protein responsible for mitochondrial transcription termination and DNA replication, consult information for MTERF1, not MTERF1P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MTERF1 pseudogene 1 (MTERF1P1).